COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care Nov 9 • 3 min read COMPASS Pathways plc has joined the Psychiatry Consortium, an international collaboration to accelerate drug discovery and development in areas of urgent, unmet medical need.
Mydecine Innovations Group Retains KCSA Strategic Communications Nov 6 • 4 min read Mydecine Innovations Group announced that it has retained KCSA Strategic Communications as its agency of record.
Cybin Completes Reverse Take-Over Transaction Nov 5 • 10 min read CYBIN Inc. announced it has completed its previously announced reverse takeover of Clarmin Explorations Inc.
Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Signs Psilocybin Manufacturing Agreement Nov 5 • 5 min read Nova Mentis Life Science Corp. announced that its pending acquisition target, Pilz Bioscience Corp., has entered into a psilocybin manufacturing agreement with a pharmaceutical company with over 800 employees.
MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD Nov 2 • 6 min read MindMed announced the completion and publication of a Phase 1 study on LSD effects.